Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

Dalhousie University

$28,000.00

Regulation of Xenobiotic- and Endobiotic-Metabolizing Enzyme Expression and Function

FY 2024-25

Summary
Xenobiotic/endobiotic-metabolizing enzymes catalyze the bioactivation and detoxification of drugs, carcinogens, environmental toxicants, and endogenous chemicals. A LONG-TERM GOAL of my research program is to understand how biochemical, molecular, and cellular factors regulate these enzymes and their biological functions, thereby advancing the fundamental science underlying individual variations in response to chemicals. A focus of my research program is on a xenobiotic/endobiotic-metabolizing enzyme known as aldehyde oxidase-1 (AOX1), which metabolizes azaheterocyclic drugs, other xenobiotics, and endogenous chemicals of physiological importance. It has contributed to chemical-induced toxicity in humans and failures in drug development. AOX1 expression and catalytic activity show large individual variations, but the underlying mechanisms for this biological phenomenon and its physiological functions are not known. Given the large knowledge gap on the fundamental biology of AOX1, an increasingly important yet relatively uncharacterized enzyme expressed in many tissues, the OVERALL OBJECTIVE of my current NSERC DG application is to unravel the fundamental mechanisms regulating AOX1 gene expression and function, and determine how genetic and non-genetic factors impact AOX1 biological functions. The SPECIFIC AIMS are to 1) elucidate the biochemical, molecular, and cellular mechanisms by which various nuclear receptors transcriptionally regulate AOX1 expression and function; 2) investigate how naturally-occurring AOX1 genetic variants affect its expression, chemical-enzyme interaction, and enzymatic function; and 3) explore the role of microRNAs (epigenetic modulators) in the post-transcriptional regulation of AOX1 expression and function. METHODOLOGY. The experimental approaches will include various biochemical, molecular biology, and pharmacological techniques in cell culture models. State-of-art technologies, including ultra-high-performance liquid chromatography-tandem mass spectrometry, quantitative targeted proteomics, chromatin immunoprecipitation-sequencing, and gene editing, will be used. IMPACT. My research program will discover new fundamental concepts of AOX1 regulation by nuclear receptors, genetic/transcript variants, microRNAs, various exogenous/endogenous chemicals, and the complex interplay or cross-regulation among the regulatory factors. The mechanistic information generated will 1) identify novel biochemical and molecular approaches to modulate the biological function of an enzyme; 2) provide novel insights into the molecular and genetic basis on why individuals respond differently to certain drugs, toxicants, other xenobiotics, and endogenous chemicals; and 3) allow us to predict individual variations in AOX1-mediated chemical action and toxicity. My research program will train the next generation of research scientists for the life sciences/biotechnology/pharmaceutical sectors in Canada.
Program
Discovery Grants Program - Individual
Location
Nova Scotia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
RGPIN-2022-03342
Name nom
Lau, Aik Jiang
Department département
College of Pharmacy
Organization id
79
Institution établissement
Dalhousie University
Province en
Nova Scotia
Province fr
Nouvelle-Écosse
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2022
Award amount
28000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1502
Committee name en
Biological Systems and Functions
Committee name fr
Systèmes et fonctions biologiques
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
6404
Research subject group en
Life sciences research related to human health and disease
Research subject group fr
Sciences de la vie liées à la santé publique et aux maladies humaines
Research subject en
Pharmacology
Research subject fr
Pharmacologie
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Regulation of Xenobiotic- and Endobiotic-Metabolizing Enzyme Expression and Function
Keywords
xenobiotic/endobiotic-metabolizing enzyme; aldehyde oxidase; enzyme function; metabolism; endogenous chemicals and hormones; nuclear receptor; gene expression and regulation; pharmacology and toxicology; genetic variant; microrna
Application summary
Xenobiotic/endobiotic-metabolizing enzymes catalyze the bioactivation and detoxification of drugs, carcinogens, environmental toxicants, and endogenous chemicals. A LONG-TERM GOAL of my research program is to understand how biochemical, molecular, and cellular factors regulate these enzymes and their biological functions, thereby advancing the fundamental science underlying individual variations in response to chemicals. A focus of my research program is on a xenobiotic/endobiotic-metabolizing enzyme known as aldehyde oxidase-1 (AOX1), which metabolizes azaheterocyclic drugs, other xenobiotics, and endogenous chemicals of physiological importance. It has contributed to chemical-induced toxicity in humans and failures in drug development. AOX1 expression and catalytic activity show large individual variations, but the underlying mechanisms for this biological phenomenon and its physiological functions are not known. Given the large knowledge gap on the fundamental biology of AOX1, an increasingly important yet relatively uncharacterized enzyme expressed in many tissues, the OVERALL OBJECTIVE of my current NSERC DG application is to unravel the fundamental mechanisms regulating AOX1 gene expression and function, and determine how genetic and non-genetic factors impact AOX1 biological functions. The SPECIFIC AIMS are to 1) elucidate the biochemical, molecular, and cellular mechanisms by which various nuclear receptors transcriptionally regulate AOX1 expression and function; 2) investigate how naturally-occurring AOX1 genetic variants affect its expression, chemical-enzyme interaction, and enzymatic function; and 3) explore the role of microRNAs (epigenetic modulators) in the post-transcriptional regulation of AOX1 expression and function. METHODOLOGY. The experimental approaches will include various biochemical, molecular biology, and pharmacological techniques in cell culture models. State-of-art technologies, including ultra-high-performance liquid chromatography-tandem mass spectrometry, quantitative targeted proteomics, chromatin immunoprecipitation-sequencing, and gene editing, will be used. IMPACT. My research program will discover new fundamental concepts of AOX1 regulation by nuclear receptors, genetic/transcript variants, microRNAs, various exogenous/endogenous chemicals, and the complex interplay or cross-regulation among the regulatory factors. The mechanistic information generated will 1) identify novel biochemical and molecular approaches to modulate the biological function of an enzyme; 2) provide novel insights into the molecular and genetic basis on why individuals respond differently to certain drugs, toxicants, other xenobiotics, and endogenous chemicals; and 3) allow us to predict individual variations in AOX1-mediated chemical action and toxicity. My research program will train the next generation of research scientists for the life sciences/biotechnology/pharmaceutical sectors in Canada.
Dalhousie University - $28,000 Grant (2024-25) | Canada Spends